Category: Other

PharmaSignal — Other

S16 Ep42: Variability and Innovation in Small Cell Lung Cancer Care: With Ticiana Leal, MD

OncLive Podcast

In today’s episode, we spoke with Ticiana Leal, MD, about variability in community practice and evolving treatment strategies for patients with small cell lung cancer (SCLC).

OtherRead full story

Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026

BioPharma Dive

The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing what s been observed over a similar timeframe in prior years, according to

OtherRead full story

One in four diabetics has undiagnosed heart failure; study

Pharmaphorum

A study has found that undiagnosed heart failure can be detected in people with high-risk diabetes using a simple, GP-led care pathway.

OtherRead full story

Trustworthy AI in clinical oversight

BioPharma Dive

AI can accelerate clinical work and preserve traceability, but only if users can trust it.

OtherRead full story

S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC

OncLive Podcast

In this podcast, experts Narjust Florez, MD, FASCO; David Carbone, MD, PhD; and Edward Garon, MD, MS; discuss the use of KRAS-, NRG1-, MET-, and ROS1-targeting agents to transform patient care in adva

OtherRead full story

NOW AVAILABLE: The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels

I am pleased to announce Drug Channels Institute’s new 2026 Economic Report on U.S.

OtherRead full story